Boston Beer Outpaces Peers, but Short Sellers Hold Their Ground

SAM has been the standout in its peer group over the past week, gaining 11.9% against a median of around 4.9% for its closest beverage names. TAP added 6.8% and STZ 7.3% over the same period, while BF.B rose 5.6%. SAM's move is roughly twice the peer median, which makes the divergence notable rather than a simple sector rotation.

Short interest at 19.1% of the free float is the highest among this peer group by a considerable margin, and it has not budged meaningfully despite the recent rally. The position has grown about 14% over the past month, even as the stock has climbed 20%. Borrow costs remain low at 0.44%, and availability is running at roughly 404% of short interest, meaning there are more than four shares available to lend for every one already borrowed. The lending market is relaxed. That combination, heavy short positioning alongside cheap and plentiful borrow, suggests the shorts are not being squeezed out. They are sitting, and the rally is happening around them.

UBS raised its price target to $204 from $190 on Friday, the same day as publication, maintaining a Neutral rating. That move is notable: the target barely clears the current price of $202.28, leaving almost no room for upside in the UBS framework even after the upgrade in target. The consensus mean sits at $198, fractionally below the market price, and the analyst population is broadly neutral to negative. Goldman Sachs carries a Sell with a $169 target, while Roth Capital is the outlier in the other direction at $295. The core disagreement is one the company has been living with for several years: whether gross margin improvement, particularly the progress on Twisted Tea and the slow stabilisation of Truly, can compound into meaningful earnings growth. The bull case rests on a first-quarter gross margin of 48.3%, described as a five-year high, and the prospect of Twisted Tea reaccelerating. The bear case points to shortfall fees, elevated marketing spend, and the risk that the current valuation multiple cannot hold if volume growth disappoints.

One ownership detail worth noting: C. James Koch holds roughly 21.6% of shares outstanding per his most recent Schedule 13G/A filed in February 2026, up from 20.0% previously. No activist Schedule 13D is on the register. BlackRock added 438,724 shares as of its September quarter filing, lifting its stake to just over 10%. American Century and T. Rowe Price also added material positions in the most recently reported quarter. Insider activity from SEC EDGAR filings is stale beyond 90 days; the most recent transactions on record are director compensation grants from May with no price attached, which carry no signal about conviction. The buyback programme is also running at its smallest quarterly level in two years, with spend down 49% year-over-year in Q2 to $26.6 million.

Tuesday's print will test whether the margin trajectory that justified the stock's 20% one-month rally can be sustained against the volume pressures the short sellers have been positioned around all quarter.